Related Experiment Video
Updated: Jun 6, 2026
08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
[Vaginal birth after cesarean delivery: update 2010]
N Jastrow1, P Cantero, M Boulvain
1Service d'obstétrique, Département de gynécologie et obstétrique HUG, 1211 Genève 14. Nicole.JastrowMeyer@.hcuge.ch
Revue Medicale Suisse
|December 9, 2010
Summary
Trial of vaginal birth after cesarean (VBAC) can be safe for women with a good prognosis. Reviewing antepartum and intrapartum factors is crucial for minimizing uterine rupture risks during VBAC.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Reproductive Health
Context:
- Rising cesarean delivery rates in developed nations are linked to concerns over uterine rupture during trial of labor after cesarean (TOLAC).
- Multiple cesarean deliveries increase surgical complications and risks of abnormal placentation in subsequent pregnancies.
- Vaginal birth after cesarean (VBAC) is a viable option for carefully selected patients.
Purpose:
- To review critical antepartum and intrapartum factors essential for achieving a safe vaginal birth after cesarean (VBAC).
- To identify predictors of successful VBAC and low risk of uterine rupture.
- To inform clinical decision-making regarding TOLAC.
Summary:
- Uterine rupture is a rare but severe complication of attempting vaginal birth after cesarean (VBAC).
- Despite concerns, VBAC offers benefits over repeat cesarean deliveries, which carry higher surgical and placental complication risks.
- Selection of candidates with favorable VBAC prognosis and low uterine rupture risk is paramount.
Impact:
- Provides evidence-based guidance for clinicians managing women considering VBAC.
- Aims to support informed patient choices regarding mode of delivery.
- Contributes to optimizing maternal and infant outcomes by promoting safe VBAC practices.
Related Concept Videos
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:26Vagina
The vaginal canal is a tubular structure averaging about 10 cm in length that acts as the entryway to the female reproductive system and the passageway for menstrual flow and childbirth. The interior walls of the vagina exhibit concentric folds called rugae and are topped by an area known as the fornix, which connects with the protruding cervical portion of the uterus. This canal is comprised of an external fibrous layer, a muscular middle layer, and an inner lining with mucosal rugae, which...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...